Research Team

I am a professor in the Department of Radiation Oncology at The Ohio State University and a member of the Translational Therapeutics Program at the OSUCCC – James, where my work is focused on determining the key molecular targets in cancer metabolism and translating those findings into the clinical setting.

I am an assistant professor-clinical in the Department of Pathology at the Ohio State University. My clinical service and academic interests focus on implementing innovate laboratory tests for in vitro diagnosis, prognosis and treatment planning of cancer and endocrine diseases.

I am a professor in the Department of Chemical and Biomolecular Biological Engineering at The Ohio State University.

I am an assistant professor in the Department of Biological Chemistry and Pharmacology at The Ohio State University and a member of the Molecular Carcinogenesis and Chemoprevention Program.

I am a member of the Cancer Biology Program at the OSUCCC – James, where my research focus is on identifying new metabolic targets for therapeutic development.

I am an assistant professor in the Department of Internal Medicine at Ohio State and a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where my research focuses on the role of diet and lifestyle in cancer risk and survival, specifically among patients with gastrointestinal cancers.

We are investigating the immuno-metabolism in the brain tumor microenvironment to understand the immune suppressive mechanisms through the regulation of glia (mainly astrocyte and microglia) by brain metastasis.

As an Associate Professor in the Department of Microbial Infection & Immunity (MI&I) and the Pelotonia Institute for Immuno-Oncology (PIIO), my lab focuses on immunometabolism — dissecting and targeting the unique metabolic programs of immune cells to modulate their responses, with the goal of developing effective immunotherapy strategies for cancer and inflammatory diseases.

As a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, the long-term goal of my lab is to investigate the function and mechanism of glucose and mitochondrial metabolism in the antitumor immunity during colorectal cancer (CRC) development.

I am a member of the Molecular Carcinogenesis and Chemoprevention at the OSUCCC – James, where my research interests lie at the intersection of analytical chemistry and chemical biology, with a focus on cancer biology.

I am a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where I focus on the development of mass spectrometry (MS)-based metabolomics and proteomics tools in support of cancer research.

I am an assistant professor in the Department of Human Sciences at The Ohio State University and a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where I specialize in metabolomics studies for cancer.

I am an Associate Professor in the department of Medicinal Chemistry and Pharmacognosy at the Ohio State University.

I am the director of the Molecular and Cellular Biology Program and Laboratory in the Division of Gastroenterology, Hepatology and Nutrition (GHN) at The Ohio State University, as well as a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James.

I am an assistant professor in the Department of Biological Chemistry and Pharmacology.

I am a professor and vice chair of experimental pathology in the Department of Pathology at The Ohio State University.

I am a member of the Translational Therapeutic Program at the OSUCCC – James and the co-holder of two U.S. patents related to miRNA biomarkers for radiation biodosimetry and for monitoring bone-marrow reconstitution.

I am a member of the Translational Therapeutics Program at the OSUCCC – James, where my research focuses primarily on drug-resistant ovarian cancer and ovarian cancer therapeutics.

I am an assistant professor in the Department of Veterinary Biosciences at The Ohio State University and a member of the Translational Therapeutics Program at the OSUCCC – James, where my research focus is to study the mechanism of cancer progression and treatment resistance.

I am a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where my research focuses on the regulation of the DNA repair pathway nucleotide excision repair and its connection to cancer therapy.

I am an associate professor in the Department of Radiation Oncology at The Ohio State University and a member of the Cancer Biology Program at the OSUCCC – James, where my lab team studies the DNA damage response (DDR) and how it can be exploited for personalized medicine.

My primary research focus is to delineate the mechanistic link between mitochondrial dysfunction and pathophysiology of human diseases, and translate the findings into the development of novel mitochondrial-targeted therapies.